LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 43

Search options

  1. Article ; Online: Revelations in our own backyard: Chandra's unique Galactic Center discoveries.

    Markoff, Sera

    Proceedings of the National Academy of Sciences of the United States of America

    2010  Volume 107, Issue 16, Page(s) 7196–7201

    Abstract: Before the launch of Chandra, our Galactic Center supermassive black hole, Sgr A*, had never been positively identified outside the radio bands. A great deal has changed in the past decade, starting with the discovery that our own backyard harbors a very ...

    Abstract Before the launch of Chandra, our Galactic Center supermassive black hole, Sgr A*, had never been positively identified outside the radio bands. A great deal has changed in the past decade, starting with the discovery that our own backyard harbors a very weak, yet clearly active, galactic nucleus. I will review how this revelation has been a boon for accretion studies around black holes in general and has helped us place our own Galaxy in context within the active galactic nuclei (AGN) zoology. Chandra's exquisite resolution has also unveiled entirely new populations of faint sources and transients, as well as regions of extreme gas dynamics and hints of prior, more typical AGN-like activity in our Galactic Center.
    Language English
    Publishing date 2010-04-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.0914070107
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Revelations in our own backyard: Chandra's unique Galactic Center discoveries

    Markoff, Sera

    Proceedings of the National Academy of Sciences of the United States of America. 2010 Apr. 20, v. 107, no. 16

    2010  

    Abstract: Before the launch of Chandra, our Galactic Center supermassive black hole, Sgr A*, had never been positively identified outside the radio bands. A great deal has changed in the past decade, starting with the discovery that our own backyard harbors a very ...

    Abstract Before the launch of Chandra, our Galactic Center supermassive black hole, Sgr A*, had never been positively identified outside the radio bands. A great deal has changed in the past decade, starting with the discovery that our own backyard harbors a very weak, yet clearly active, galactic nucleus. I will review how this revelation has been a boon for accretion studies around black holes in general and has helped us place our own Galaxy in context within the active galactic nuclei (AGN) zoology. Chandra's exquisite resolution has also unveiled entirely new populations of faint sources and transients, as well as regions of extreme gas dynamics and hints of prior, more typical AGN-like activity in our Galactic Center.
    Keywords energy ; radio waves ; research
    Language English
    Dates of publication 2010-0420
    Size p. 7196-7201.
    Publishing place National Academy of Sciences
    Document type Article
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.0914070107
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article: Differences in susceptibilities of the lymphogranuloma venereum and trachoma biovars of Chlamydia trachomatis to neutralization by immune sera.

    Peterson, E M / Hoshiko, M / Markoff, B A / Lauermann, M W / de la Maza, L M

    Infection and immunity

    1990  Volume 58, Issue 4, Page(s) 938–943

    Abstract: Sera from seven patients from whom a C. trachomatis serovar L2 strain was isolated were tested ... lymph node was culture positive, whereas the remaining six patients had positive rectal biopsies. Sera ... was resistant to neutralization by the homologous sera. However, the same sera effectively neutralized ...

    Abstract Sera from seven patients from whom a C. trachomatis serovar L2 strain was isolated were tested in vitro for their ability to neutralize the infectivity of this organism. In one patient an inguinal lymph node was culture positive, whereas the remaining six patients had positive rectal biopsies. Sera from four of the patients, including the patient with the lymph node isolate, failed to neutralize serovar L2(434). In addition, the homologous strain recovered from the inguinal lymph node was available and was resistant to neutralization by the homologous sera. However, the same sera effectively neutralized a trachoma serovar, E(Bour). All four sera had inclusion immunofluorescent-antibody titers to C. trachomatis serovar L2 of 2,048 to 16,384 and microimmunofluorescent-antibody titers to the lymphogranuloma venereum biovar were equal or higher in all cases than to the 12 serovars of the trachoma biovar. The three remaining sera, while neutralizing the infectivity of the L2 strains tested, neutralized serovar E to a greater extent. These sera had the same inclusion immunofluorescent antibody titers as the sera that failed to neutralize serovar L2. To see whether this difference in the sensitivity of the biovars toward neutralization could be characterized, sera were obtained from mice immunized with different doses of both serovars L2 and E. Sera obtained from mice immunized with serovar E were able to effectively neutralize the homologous strain. In contrast, neutralization of the immunizing strain, L2(UCI-20), was not seen with sera obtained on days 7, 14, and 21 after immunization from animals receiving 8 x 10(5) and 8 x 10(4) inclusion-forming units of L2(UCI-20); however, these same sera neutralized serovar E. However, with a higher immunizing dose of L2 (10(7) IFUs), both E and L2 were neutralized with sera obtained 7 and 14 days after immunization. Therefore, the relative resistance to neutralization by serovar L2 compared with that of serovar E in the mouse model was inoculum dependent.
    MeSH term(s) Animals ; Antibodies, Bacterial/analysis ; Chlamydia trachomatis/immunology ; Chlamydia trachomatis/pathogenicity ; Female ; Humans ; Immune Sera/immunology ; Immunization ; Lymphogranuloma Venereum/microbiology ; Mice ; Mice, Inbred BALB C ; Neutralization Tests ; Trachoma/microbiology ; Virulence
    Chemical Substances Antibodies, Bacterial ; Immune Sera
    Language English
    Publishing date 1990-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 218698-6
    ISSN 1098-5522 ; 0019-9567
    ISSN (online) 1098-5522
    ISSN 0019-9567
    DOI 10.1128/iai.58.4.938-943.1990
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Elsberg syndrome in HSV-2 infection.

    Belfaqeeh, Omar / Markley, Alexandria / Patel, Mudita / Markoff, Brian / Osorio, Georgina

    IDCases

    2023  Volume 31, Page(s) e01714

    Abstract: ... Based on clinical, radiographic, and serological testing the patient was diagnosed with HSV2 lumbosacral ...

    Abstract Elsberg syndrome (ES) is a neuroinflammatory disease that causes acute or subacute lumbosacral radiculitis, with or without myelitis which accounts for approximately 5-10% of cauda equina syndrome and myelitis. We herein present a case of a middle-aged female who recently returned from the Dominican Republic and presented to the emergency room with complaints of a 10-day history of progressive lower extremity sensory changes and weakness preceded by transient bilateral arm pain and neck and head pressure. Based on clinical, radiographic, and serological testing the patient was diagnosed with HSV2 lumbosacral radiculitis (ES). After 21 days of Acyclovir, 5 days of high dose IV methylprednisolone, and one month of inpatient rehab, our patient was discharged home walking with a cane. As ES is poorly defined and rarely reported, it can be unrecognized in patients with acute cauda equina syndrome (CES). Appropriate testing for viral infection in a timely manner facilitates reaching a definitive diagnosis and prompt initiation of treatment, which is essential for resolution of symptoms.
    Language English
    Publishing date 2023-02-16
    Publishing country Netherlands
    Document type Case Reports
    ZDB-ID 2745454-X
    ISSN 2214-2509
    ISSN 2214-2509
    DOI 10.1016/j.idcr.2023.e01714
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Searching for Primordial Black Holes in the Radio and X-Ray Sky.

    Gaggero, Daniele / Bertone, Gianfranco / Calore, Francesca / Connors, Riley M T / Lovell, Mark / Markoff, Sera / Storm, Emma

    Physical review letters

    2017  Volume 118, Issue 24, Page(s) 241101

    Abstract: We model the accretion of gas onto a population of massive primordial black holes in the Milky Way and compare the predicted radio and x-ray emission with observational data. We show that, under conservative assumptions on the accretion process, the ... ...

    Abstract We model the accretion of gas onto a population of massive primordial black holes in the Milky Way and compare the predicted radio and x-ray emission with observational data. We show that, under conservative assumptions on the accretion process, the possibility that O(10)M_{⊙} primordial black holes can account for all of the dark matter in the Milky Way is excluded at 5σ by a comparison with a Very Large Array radio catalog at 1.4 GHz and at ≃40σ by a comparison with a Chandra x-ray catalog (0.5-8 keV). We argue that this method can be used to identify such a population of primordial black holes with more sensitive future radio and x-ray surveys.
    Language English
    Publishing date 2017-06-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.118.241101
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Cygnus X-1 contains a 21-solar mass black hole-Implications for massive star winds.

    Miller-Jones, James C A / Bahramian, Arash / Orosz, Jerome A / Mandel, Ilya / Gou, Lijun / Maccarone, Thomas J / Neijssel, Coenraad J / Zhao, Xueshan / Ziółkowski, Janusz / Reid, Mark J / Uttley, Phil / Zheng, Xueying / Byun, Do-Young / Dodson, Richard / Grinberg, Victoria / Jung, Taehyun / Kim, Jeong-Sook / Marcote, Benito / Markoff, Sera /
    Rioja, María J / Rushton, Anthony P / Russell, David M / Sivakoff, Gregory R / Tetarenko, Alexandra J / Tudose, Valeriu / Wilms, Joern

    Science (New York, N.Y.)

    2021  Volume 371, Issue 6533, Page(s) 1046–1049

    Abstract: The evolution of massive stars is influenced by the mass lost to stellar winds over their lifetimes. These winds limit the masses of the stellar remnants (such as black holes) that the stars ultimately produce. We used radio astrometry to refine the ... ...

    Abstract The evolution of massive stars is influenced by the mass lost to stellar winds over their lifetimes. These winds limit the masses of the stellar remnants (such as black holes) that the stars ultimately produce. We used radio astrometry to refine the distance to the black hole x-ray binary Cygnus X-1, which we found to be [Formula: see text] kiloparsecs. When combined with archival optical data, this implies a black hole mass of 21.2 ± 2.2 solar masses, which is higher than previous measurements. The formation of such a high-mass black hole in a high-metallicity system (within the Milky Way) constrains wind mass loss from massive stars.
    Language English
    Publishing date 2021-02-18
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.abb3363
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A rapidly changing jet orientation in the stellar-mass black-hole system V404 Cygni.

    Miller-Jones, James C A / Tetarenko, Alexandra J / Sivakoff, Gregory R / Middleton, Matthew J / Altamirano, Diego / Anderson, Gemma E / Belloni, Tomaso M / Fender, Rob P / Jonker, Peter G / Körding, Elmar G / Krimm, Hans A / Maitra, Dipankar / Markoff, Sera / Migliari, Simone / Mooley, Kunal P / Rupen, Michael P / Russell, David M / Russell, Thomas D / Sarazin, Craig L /
    Soria, Roberto / Tudose, Valeriu

    Nature

    2019  Volume 569, Issue 7756, Page(s) 374–377

    Abstract: Powerful relativistic jets are one of the main ways in which accreting black holes provide kinetic feedback to their surroundings. Jets launched from or redirected by the accretion flow that powers them are expected to be affected by the dynamics of the ... ...

    Abstract Powerful relativistic jets are one of the main ways in which accreting black holes provide kinetic feedback to their surroundings. Jets launched from or redirected by the accretion flow that powers them are expected to be affected by the dynamics of the flow, which for accreting stellar-mass black holes has shown evidence for precession
    Language English
    Publishing date 2019-04-29
    Publishing country England
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, Non-U.S. Gov't
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/s41586-019-1152-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The nature of the IR emission in LLAGN at parsec scales

    Fernández-Ontiveros Juan Antonio / Almudena Prieto M. / Acosta-Pulido Jose Antonio / Markoff Sera / González-Martín Omaira

    EPJ Web of Conferences, Vol 61, p

    2013  Volume 04005

    Abstract: The vast majority of AGN belong to the low-luminosity class (LLAGN): they exhibit a low radiation effciency (L ≲ 1042 erg s−1; L/Ledd ≲ 10−3) and the absence of the big blue bump in their spectrum, a signature of the accretion disk. The study of LLAGN is ...

    Abstract The vast majority of AGN belong to the low-luminosity class (LLAGN): they exhibit a low radiation effciency (L ≲ 1042 erg s−1; L/Ledd ≲ 10−3) and the absence of the big blue bump in their spectrum, a signature of the accretion disk. The study of LLAGN is a complex task due to the contribution of the host galaxy, whose light outshines these faint nuclei. As a consequence, numerical models are usually compared with relatively poorly defined spectral energy distributions (SEDs). For a sample of six prototype nearby LLAGN, a multiwavelength dataset including radio, IR, optical/UV and X-ray measurements with a few tenths of arcsec resolution has been collected. These high-spatial resolution SEDs reveal that: i) the mid-IR bump, indicative of thermal emission from the torus, is missing in LLAGN; ii) the continuum emission of these nuclei is largely described by a self-absorbed synchrotron spectrum, suggesting that jet emission dominates the overall energy output in these objects. The optically thin radiation in the IR-to-UV range is produced in the jet launching region, very close to the central black hole. The very steep slope found in this component –with a spectral index in the 1-3 range– suggests that a large number of LLAGN are powered by young and compact jets with very high radiative losses.
    Keywords Physics ; QC1-999 ; Science ; Q ; DOAJ:Physics (General) ; DOAJ:Physics and Astronomy
    Subject code 520
    Language English
    Publishing date 2013-12-01T00:00:00Z
    Publisher EDP Sciences
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Ethics of a partially effective dengue vaccine: Lessons from the Philippines.

    Halstead, Scott B / Katzelnick, Leah C / Russell, Philip K / Markoff, Lewis / Aguiar, Maira / Dans, Leonila R / Dans, Antonio L

    Vaccine

    2020  Volume 38, Issue 35, Page(s) 5572–5576

    Abstract: ... children who had prior dengue virus (DENV) infections but sensitized seronegative children to breakthrough ... vaccinated seronegative and seropositive children hospitalized for severe dengue. Assisting these children ... of an acceptable serological screening test these unresolved ethical issues suggest Dengvaxia be given only ...

    Abstract Dengvaxia, a chimeric yellow fever tetravalent dengue vaccine developed by SanofiPasteur is widely licensed in dengue-endemic countries. In a large cohort study Dengvaxia was found to partially protect children who had prior dengue virus (DENV) infections but sensitized seronegative children to breakthrough DENV disease of enhanced severity. In 2019, the European Medicines Agency and the US FDA issued licenses that reconciled safety issues by restricting vaccine to individuals with prior dengue infections. Using revised Dengvaxia efficacy and safety data we sought to estimate hospitalized and severe dengue cases among the more than 800,000 9 year-old children vaccinated in the Philippines. Despite an overall vaccine efficacy of 69% during 4 years post-vaccination we project there will be more than one thousand vaccinated seronegative and seropositive children hospitalized for severe dengue. Assisting these children through a program of enhanced surveillance leading to improved care deserves widespread support. Clinical responses observed during breakthrough dengue infections in vaccinated individuals counsel prudence in design of vaccine policies. Recommendations concerning continued use of this dengue vaccine are: (1) obtain a better definition of vaccine efficacy and safety through enhanced phase 4 surveillance, (2) obtain a valid, accessible, sensitive, specific and affordable serological test that identifies past wild-type dengue virus infection and (3) clarify safety and efficacy of Dengvaxia in flavivirus immunes. In the absence of an acceptable serological screening test these unresolved ethical issues suggest Dengvaxia be given only to those signing informed consent.
    MeSH term(s) Antibodies, Viral ; Child ; Cohort Studies ; Dengue/prevention & control ; Dengue Vaccines/adverse effects ; Humans ; Philippines ; Vaccines, Attenuated
    Chemical Substances Antibodies, Viral ; Dengue Vaccines ; Vaccines, Attenuated
    Keywords covid19
    Language English
    Publishing date 2020-07-10
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2020.06.079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines.

    Markoff, L

    Vaccine

    2000  Volume 18 Suppl 2, Page(s) 26–32

    Abstract: ... for the efficacy of JE vaccines should be established. Detection of virus-neutralizing antibodies in sera ... by the vaccines and protection from encephalitis. In addition, sera of subjects receiving the novel live JEV ...

    Abstract Although an effective killed virus vaccine to prevent illness due to Japanese encephalitis virus (JEV) infection exists, many authorities recognize that a safe, effective live JEV vaccine is desirable in order to reduce the cost and the number of doses of vaccine required per immunization. A large-scale clinical efficacy trail for such a vaccine would be both unethical and impractical. Therefore, a surrogate for the efficacy of JE vaccines should be established. Detection of virus-neutralizing antibodies in sera of vaccinees could constitute such a surrogate for efficacy. Field studies of vaccinees in endemic areas and studies done in mice already exist to support this concept. Also, titers of virus-neutralizing antibodies are already accepted as a surrogate for the efficacy of yellow fever virus vaccines and for the efficacy of other viral vaccines as well. In developing a correlation between N antibody titers and protection from JEV infection, standard procedures must be validated and adopted for both measuring N antibodies and for testing in animals. A novel live virus vaccine could be tested in the mouse and/or the monkey model of JEV infection to establish a correlation between virus-neutralizing antibodies elicited by the vaccines and protection from encephalitis. In addition, sera of subjects receiving the novel live JEV vaccine in early clinical trials could be passively transferred to mice or monkeys in order to establish the protective immunogenicity of the vaccine in humans. A monkey model for JEV infection was recently established by scientists at WRAIR in the US. From this group, pools of JEV of known infectivity for Rhesus macaques may be obtained for testing of immunity elicited by live JE vaccine virus.
    MeSH term(s) Animals ; Clinical Trials as Topic ; Dose-Response Relationship, Immunologic ; Encephalitis Virus, Japanese/immunology ; Encephalitis, Japanese/epidemiology ; Encephalitis, Japanese/immunology ; Encephalitis, Japanese/prevention & control ; Humans ; Practice Guidelines as Topic ; Vaccines, Attenuated/adverse effects ; Vaccines, Attenuated/economics ; Vaccines, Attenuated/standards ; Vaccines, Attenuated/therapeutic use ; Viral Vaccines/adverse effects ; Viral Vaccines/economics ; Viral Vaccines/standards ; Viral Vaccines/therapeutic use
    Chemical Substances Vaccines, Attenuated ; Viral Vaccines
    Language English
    Publishing date 2000-05-26
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/s0264-410x(00)00038-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top